Table 1.
Characteristics of Eligible Studies
| Study, First Author | Publication Year | Location | Setting | Screening | Method | No.a | no. (%)b | Dominant Strain | Quality Score |
|---|---|---|---|---|---|---|---|---|---|
| Europe | |||||||||
| Oliva [S1] | 2013 | Italy | Outpatient ID clinic | N | C | 68 | 2 (2.9) | NR | 5 |
| Outpatient ID clinic | N | C | 63 | 0 (0.0) | NA | ||||
| Joore [S2] | 2013 | Netherlands | Outpatient MSM in STI clinic | N, T, P | C | 42 | 1 (2.38) | Spa-type t064 | 4 |
| Giuliani [S3] | 2010 | Italy | Outpatient MSM in HIV clinic | N | C | 104 | 0 (0.0) | NA | 4 |
| Seybold [S4] | 2009 | Germany | Outpatient ID clinic | N | C | 100 | 2 (2.0) | NR | 5 |
| Sissolak [S5] | 2002 | Austria | Within 48 h of admission | N | C | 47 | 0 (0.0) | NA | 4 |
| Weinke [S6] | 1992 | Germany | Outpatient and hospitalized | N, T | C | 136 | 0 (0.0) | NA | 5 |
| North America (US, Canada) | |||||||||
| Popovich [S7] | 2013 | Indiana, US | Within 72 h of hospitalization | N, A, G, P, T, W | C | 374 | 76 (20.3) | USA300 | 5 |
| Farley [S8] | 2013 | Maryland, US | Within 72 h of hospitalization | N, A, W | C | 68 | 10 (14.7) | USA300 | 4 |
| Peters [S9] | 2013 | Georgia, US | Outpatient HIV clinic | N, G | C | 600 | 79 (13.2) | USA300 | 5 |
| Popovich [S10] | 2012 | Indiana, US | Outpatient HIV clinic | N | C | 458 | 50 (10.9) | USA300 | 4 |
| Schechter-Perkins [S11] | 2011 | Massachusetts, US | ED | N, G, P, T, W, S | C | 11 | 4 (36.4) | USA300 | 5 |
| Crum-Cianflone [S12] | 2011 | California, US | Outpatient military HIV clinic | N, A, G, T, P | NR | 312 | 7 (2.2) | USA300 (in total) | 5 |
| Washington, D.C., US | Outpatient military HIV clinic | N, A, G, T, P | NR | 169 | 10 (5.9) | ||||
| Texas, US | Outpatient military HIV clinic | N, A, G, T, P | NR | 44 | 4 (9.1) | ||||
| Virginia, US | Outpatient military HIV clinic | N, A, G, T, P | NR | 25 | 1 (4.0) | ||||
| Alexander [S13] | 2011 | New York, US | Dialysis center | N | C | 15 | 1 (6.67) | NR | |
| Mermel [S14] | 2010 | Ohio, US | Inpatient | N | C | 161 | 5 (3.1) | USA300 (in total) | 5 |
| Maryland, US | Outpatient | N | C | 494 | 78 (15.8) | ||||
| Madariaga [S15] | 2009 | Nebraska, US | Outpatient HIV clinic | N, P | C | 100 | 2 (2) | NR | 4 |
| Antoniou [S16] | 2009 | Toronto, Canada | Outpatient clinic MSM | N, P | C | 298 | 4 (1.3) | USA300 | 4 |
| Shet [S17] | 2009 | New York, US | Outpatient HIV clinic | N, A | C | 107 | 18 (16.8) | USA300 | 5 |
| Farley [S18] | 2008 | Maryland, US | Within 24 h from arrest | N, W | C | 30 | 4 (13.3) | NR | 4 |
| Cenizal [S19] | 2008 | Texas, US | Outpatient HIV clinic | N, A | C | 146 | 15 (10.3) | USA300 | 5 |
| Hidron [S20] | 2005 | Georgia, US | Within 48 h of hospitalization | N | C | 81 | 14 (17.3) | NR | 5 |
| Miller [S21] | 2003 | New York, US | Community former and current drug users | N | C | 193 | 8 (4.2) | NR | 4 |
| Klein [S22] | 1997 | New York, US | Outpatient dermatology | N, A, W | C | 33 | 0 (0) | NA | 4 |
| Raviglione [S23] | 1990 | New York, US | Within 24 h of hospitalization | N | C | 64 | 3 (4.7) | NR | 5 |
| South America | |||||||||
| Reinato [S24] | 2013 | Brazil | Within 24 h of hospitalization | N | C | 169 | 10 (5.9) | NR | 5 |
| Padoveze [S25] | 2008 | Brazil | Outpatient HIV center | N | C | 111 | 0 (0.0) | NA | 5 |
| Padoveze [S26] | 2001 | Brazil | Outpatient HIV center | N | C | 126 | 48 (38.1) | NR | 5 |
| Inpatient | N | C | 52 | 14 (26.9) | |||||
| Asia | |||||||||
| Chow [S27] | 2012 | Singapore | On hospital admission | N, A, G, P, T, W | C | 914 | 96 (10.5) | NR | 5 |
| Kyaw [S28] | 2012 | Singapore | Outpatient HIV center | N, A, G, P, T | C | 296 | 15 (5.1) | NR | 5 |
| MohdNawi [S29] | 2012 | Malaysia | Outpatient | N, A, T | C | 130 | 1 (0.8) | NR | 4 |
| Chacko [S30] | 2009 | India | Outpatient dermatology center | N | C | 60 | 8 (13.3) | NR | 4 |
| Villacian [S31] | 2004 | Singapore | Outpatient HIV clinic | N | C | 195 | 6 (3.1) | NR | 5 |
| McDonald [S32] | 2003 | Taiwan | Outpatient ID clinic | N | C | 162 | 9 (5.6) | NR | 5 |
The references of eligible studies are provided in the Supplementary Appendix.
Abbreviations: A, axilla; C, culture; ED, emergency department; G, groin; HIV, human immunodeficiency virus; ID, infectious disease; MSM, men who have sex with men; N, nares; NA, not applicable; NR, not reported; P, perirectal; S, skin (palms of both hands); STI, sexually transmitted infection; T, throat; W, wound.
a Number of patients who were screened for methicillinresistant Staphylococcus aureus (MRSA) colonization.
b Number of patients who were found to be MRSA colonized.